Patents by Inventor Ole Schmeltz Sogaard

Ole Schmeltz Sogaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING A LATENT HIV-1 INFECTION USING NON-CODING DEOXYRIBONUCLEIC ACIDS
    Publication number: 20230310594
    Abstract: The invention relates to a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N1N2CGN3N4, wherein N is a nucleotide comprising A, C, T, or G, and C is deoxycytidine, G is deoxyguanosine, A is deoxyadenosine and T is deoxythymidine for the treatment of viral infections. In particular, the non-coding sequence of deoxyribonucleic acids is used in combination with antiretroviral therapy and/or histone de-acetylase inhibitors.
    Type: Application
    Filed: January 11, 2023
    Publication date: October 5, 2023
    Inventors: Matthias Schroff, Manuel Schmidt, Kerstin Kapp, Alfredo Zurlo, Ole Schmeltz Sogaard, Martin Tolstrup, Rasmus Offersen
  • Methods of treating a retroviral infection
    Patent number: 11583581
    Abstract: The invention relates to a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N1N2CGN3N4, wherein N is a nucleotide comprising A, C, T, or G, and C is deoxycytidine, G is deoxyguanosine, A is deoxyadenosine and T is deoxy-thymidine for the treatment of viral infections. In particular, the non-coding sequence of deoxyribonucleic acids is used in combination with antiretroviral therapy and/or histone de-acetylase inhibitors.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: February 21, 2023
    Assignee: Gilead Sciences, Inc.
    Inventors: Matthias Schroff, Manuel Schmidt, Kerstin Kapp, Alfredo Zurlo, Ole Schmeltz Sogaard, Martin Tolstrup, Rasmus Offersen
  • MEANS FOR THE TREATMENT OF HIV
    Publication number: 20200230234
    Abstract: The invention relates to a non-coding sequence of deoxyribonucleic acids comprising at least one sequence motif N1N2CGN3N4, wherein N is a nucleotide comprising A, C, T, or G, and C is deoxycytidine, G is deoxyguanosine, A is deoxyadenosine and T is deoxy-thymidine for the treatment of viral infections. In particular, the non-coding sequence of deoxyribonucleic acids is used in combination with antiretroviral therapy and/or histone de-acetylase inhibitors.
    Type: Application
    Filed: September 21, 2016
    Publication date: July 23, 2020
    Applicant: MOLOGEN AG
    Inventors: Matthias SCHROFF, Manuel SCHMIDT, Kerstin KAPP, Alfredo ZURLO, Ole SCHMELTZ SOGAARD, Martin TOLSTRUP, Rasmus OFFERSEN
  • Pneumococcal vaccine and uses thereof
    Patent number: 9205143
    Abstract: The present invention relates to new pneumococcal vaccines. The invention also relates to vaccination of subjects, in particular immunocompromised subjects, against pneumoccocal infections using said novel pneumococcal vaccines.
    Type: Grant
    Filed: October 9, 2013
    Date of Patent: December 8, 2015
    Assignee: Coley Pharmaceutical Group Inc.
    Inventors: Heather Lynn Davis, Arthur Mertz Krieg, Nicolai Lohse, Lars Ostergaard, Henrik Carl Schonheyder, Ole Schmeltz Sogaard
  • PANOBINOSTAT FOR USE IN THE TREATMENT OF HIV-1
    Publication number: 20150031739
    Abstract: The present invention relates to uses and methods involving Panobinostat and HIV-1. In particular relates the present invention to Panobinostat for use in the treatment of HIV-1 and especially latent HIV-1. This is done using a low dosage of Panobinostat which is highly effective in depleting the HIV-1 reservoir.
    Type: Application
    Filed: January 25, 2013
    Publication date: January 29, 2015
    Applicants: Aarhus Universitet, Region Midtjylland
    Inventors: Martin Tolstrup, Thomas Aagaard Rasmussen, Lars Østergaard, Ole Schmeltz Søgaard, Christel Rothe Brinkmann
  • Pneumococcal Vaccine and Uses Thereof
    Publication number: 20140099337
    Abstract: The present invention relates to new pneumococcal vaccines. The invention also relates to vaccination of subjects, in particular immunocompromised subjects, against pneumoccocal infections using said novel pneumococcal vaccines.
    Type: Application
    Filed: October 9, 2013
    Publication date: April 10, 2014
    Applicant: COLEY PHARMACEUTICAL GROUP INC.
    Inventors: Heather Lynn Davis, Arthur Mertz Krieg, Nicolai Lohse, Lars Ostergaard, Henrik Carl Schonheyder, Ole Schmeltz Sogaard
  • PNEUMOCOCCAL VACCINE AND USES THEREOF
    Publication number: 20120052088
    Abstract: The present invention relates to new pneumococcal vaccines. The invention also relates to vaccination of subjects, in particular immunocompromised subjects, against pneumococcal infections using said novel pneumococcal vaccines.
    Type: Application
    Filed: March 17, 2010
    Publication date: March 1, 2012
    Applicant: COLEY PHARMACEUTICAL GROUP, INC.
    Inventors: Heather Lynn Davis, Arthur Mertz Krieg, Nicolai Lohse, Lars Ostergaard, Henrik Carl Schonheyder, Ole Schmeltz Sogaard